作者:
Dafni, U. [1]
;
Michielin, O. [2]
;
Lluesma, S. Martin [3]
;
Tsourti, Z. [4]
;
Polydoropoulou, V. [5]
;
Karlis, D. [6]
;
Besser, M. J. [7]
;
Haanen, J. [8]
;
Svane, I. -M. [9]
;
Ohashi, P. S. [10]
;
Kammula, U. S. ;
Orcurto, A. ;
Zimmermann, S. ;
Trueb, L. ;
Klebanoff, C. A. ;
Lotze, M. T. ;
Kandalaft, L. E. ;
Coukos, G.
作者单位:
Herlev Hosp, Ctr Canc Immune Therapy, Dept Hematol & Oncol, Herlev, Denmark
[1]
Univ Pittsburgh, Sch Hlth Sci, Dept Immunol, Pittsburgh, PA USA
[2]
Ella Inst Treatment & Res Melanoma & Skin Canc, Sheba Med Ctr, Tel Aviv, Israel
[3]
Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[4]
Univ Toronto, Princess Margaret Canc Ctr, Dept Immunol, Toronto, ON, Canada
[5]
Athens Univ Econ & Business, Dept Stat, Athens, Greece
[6]
Univ Lausanne, CHUV, Dept Oncol, Rue Bugnon 46, CH-1011 Lausanne, Switzerland
[7]
Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, 1275 York Ave, New York, NY 10021 USA
[8]
Sci Res Consulting Hellas, Stat Ctr, Athens, Greece
[9]
Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA
[10]
发布时间
2021-09-23